Document is current

Article History

Received: 21 March 2023

Revised: 24 June 2023

Accepted: 4 July 2023

First Online: 17 August 2023

Declarations

:

: The scientific guarantor of this publication is Sang Hyun Choi.

: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

: Sehee Kim kindly provided statistical advice for this manuscript.

: Written informed consent was waived by the Institutional Review Board.

: Institutional Review Board approval was obtained by Asan Medical Center.

: Of the 370 patients enrolled in this study, imaging findings of 179 patients were reported in a recently published article (J Hepatol:). In contrast, methods of evaluation differed markedly, in that the previous study assessed the value of threshold growth in the diagnosis of HCC, whereas the present study evaluated the clinical usefulness of threshold growth based on tumor growth rate. Moreover, the present study utilized different inclusion criteria (i.e., nodule size 1.0–3.0 cm), encompassed a longer study period (from January 2016 to December 2020), and included a larger number of study subjects.

: • Retrospective• Diagnostic study• Performed at one institution